These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36342287)

  • 41. Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates.
    Pirnay JP; De Vos D; Mossialos D; Vanderkelen A; Cornelis P; Zizi M
    Environ Microbiol; 2002 Dec; 4(12):872-82. PubMed ID: 12534469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.
    Ocampo-Sosa AA; Cabot G; Rodríguez C; Roman E; Tubau F; Macia MD; Moya B; Zamorano L; Suárez C; Peña C; Domínguez MA; Moncalián G; Oliver A; Martínez-Martínez L;
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1703-13. PubMed ID: 22290967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genotypes, carbapenemase carriage, integron diversity and oprD alterations among carbapenem-resistant Pseudomonas aeruginosa from Russia.
    Bocharova Y; Savinova T; Lazareva A; Polikarpova S; Gordinskaya N; Mayanskiy N; Chebotar I
    Int J Antimicrob Agents; 2020 Apr; 55(4):105899. PubMed ID: 31931151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan.
    Sanbongi Y; Shimizu A; Suzuki T; Nagaso H; Ida T; Maebashi K; Gotoh N
    Microbiol Immunol; 2009 Jul; 53(7):361-7. PubMed ID: 19563394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
    J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ
    Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution of carbapenem resistance mechanisms in Pseudomonas aeruginosa isolates among hospitalised children in Poland: Characterisation of two novel insertion sequences disrupting the oprD gene.
    Wołkowicz T; Patzer JA; Kamińska W; Gierczyński R; Dzierżanowska D
    J Glob Antimicrob Resist; 2016 Dec; 7():119-125. PubMed ID: 27750158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa.
    De Rosa A; Mutters NT; Mastroianni CM; Kaiser SJ; Günther F
    Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1547-1552. PubMed ID: 31152264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
    Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S
    Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study.
    Courtois N; Caspar Y; Maurin M
    Int J Antimicrob Agents; 2018 Sep; 52(3):358-364. PubMed ID: 29775685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients.
    Colque CA; Albarracín Orio AG; Feliziani S; Marvig RL; Tobares AR; Johansen HK; Molin S; Smania AM
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071060
    [No Abstract]   [Full Text] [Related]  

  • 52. SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds.
    Martins WMBS; Narciso AC; Cayô R; Santos SV; Fehlberg LCC; Ramos PL; da Cruz JB; Gales AC
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):221-227. PubMed ID: 29224710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular characterizations of antibiotic resistance, biofilm formation, and virulence determinants of Pseudomonas aeruginosa isolated from burn wound infection.
    Ghasemian S; Karami-Zarandi M; Heidari H; Khoshnood S; Kouhsari E; Ghafourian S; Maleki A; Kazemian H
    J Clin Lab Anal; 2023 Apr; 37(4):e24850. PubMed ID: 36808649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung.
    Diaz Caballero J; Clark ST; Coburn B; Zhang Y; Wang PW; Donaldson SL; Tullis DE; Yau YC; Waters VJ; Hwang DM; Guttman DS
    mBio; 2015 Sep; 6(5):e00981-15. PubMed ID: 26330513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbapenem-resistant Pseudomonas aeruginosa strains: a worrying health problem in intensive care units.
    Souza GHA; Rossato L; Brito GT; Bet GMDS; Simionatto S
    Rev Inst Med Trop Sao Paulo; 2021; 63():e71. PubMed ID: 34586305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of a hospital outbreak related to carbapenem-resistant Pseudomonas aeruginosa].
    Cekin Y; Karagöz A; Kızılateş F; Cekin AH; Oztoprak Çuvalcı N; Bülbüller N; Durmaz R
    Mikrobiyol Bul; 2013 Oct; 47(4):619-27. PubMed ID: 24237430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of Pseudomonas aeruginosa isolates from patients with urinary tract infections during antibiotic therapy.
    Horii T; Muramatsu H; Morita M; Maekawa M
    Microb Drug Resist; 2003; 9(2):223-9. PubMed ID: 12820809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele.
    Shu JC; Su LH; Chiu CH; Kuo AJ; Liu TP; Lee MH; Su IN; Wu TL
    Microb Drug Resist; 2015 Apr; 21(2):149-57. PubMed ID: 25386722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acquisition of different carbapenem resistance mechanisms by an epidemic clonal lineage of Pseudomonas aeruginosa.
    Edalucci E; Spinelli R; Dolzani L; Riccio ML; Dubois V; Tonin EA; Rossolini GM; Lagatolla C
    Clin Microbiol Infect; 2008 Jan; 14(1):88-90. PubMed ID: 17986266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Location of OprD porin in Pseudomonas aeruginosa clinical isolates.
    González-Vázquez MC; Rocha-Gracia RDC; Carabarín-Lima A; Bello-López E; Huerta-Romano F; Martínez-Laguna Y; Lozano-Zarain P
    APMIS; 2021 Apr; 129(4):213-224. PubMed ID: 33471435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.